Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CRN on ODS

This article was originally published in The Tan Sheet

Executive Summary

NIH's Office of Dietary Supplements "should overtly and in a transparent manner offer its reports as advice," CRN VP-Scientific & International Affairs John Hathcock, PhD, said in materials presented during a meeting on ODS' five-year Strategic Plan May 20 in Bethesda, Md. Hathcock noted that some needs are not being met to expand outreach to the public, scientists and healthcare providers. The CRN VP also recommended that the HHS secretary and agency heads at CDC and NIH "should overtly seek and consider the advice of ODS on [dietary supplement] issues"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098250

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel